Contribution of nitric oxide to cutaneous microvascular dilation in individuals with type 2 diabetes mellitus

Abstract

Microvascular pathophysiology associated with type 2 diabetes mellitus (T2DM) contributes to several aspects of the morbidity associated with the disease. We quantified the contribution of nitric oxide (NO) to the cutaneous vasodilator response to nonpainful local warming in subjects with T2DM (average duration of diabetes mellitus 7 ± 1 yr) and in age-matched control subjects. We measured skin blood flow in conjunction with intradermal microdialysis of NG-nitro-l-arginine methyl ester (l-NAME; NO synthase inhibitor) or vehicle during 35 min of local warming to 42°C. Microdialysis of sodium nitroprusside (SNP) was used for assessment of maximum cutaneous vascular conductance (CVC). Resting CVC was higher in T2DM subjects at vehicle sites (T2DM: 19 ± 2 vs. control: 11 ± 3%maxCVC; P < 0.05); this difference was abolished by l-NAME (T2DM: 10 ± 1 vs. control: 8 ± 1%maxCVC; P > 0.05). The relative contribution of NO to the vasodilator response to local warming was not different between groups (T2DM: 46 ± 4 vs. control: 44 ± 6%maxCVC; P > 0.05). However, absolute CVC during local warming was ∼25% lower in T2DM subjects (T2DM: 1.79 ± 0.15 AU/mmHg; controls: 2.42 ± 0.20 AU/mmHg; P < 0.01), and absolute CVC during SNP was ∼20% lower (T2DM: 1.91 ± 0.12 vs. control: 2.38 ± 0.13 AU/mmHg; P < 0.01). We conclude that the relative contribution of NO to vasodilation during local warming is similar between subjects with T2DM and control subjects, although T2DM was associated with a lower absolute maximum vasodilation.